Discover
GALT
Galectin Therapeutics Inc.
4.33
2 x 3.24
2 x 5.51
bid
ask
-
0.31
6.68%
2 @ 04:00 PM
4.45 +0.12 (2.77%)
| Ytd | 4.09% | |
| 1y | 95.05% |
4.28
day range
4.61
2.03
52 week range
7.13
| Open | 4.57 | Prev Close | 4.64 | Low | 4.28 | High | 4.61 | Mkt Cap | 285.16M |
| Vol | 646.55K | Avg Vol | 578.37K | EPS | -0.41 | P/E | N/A | Forward P/E | -0.53 |
| Beta | 0.63 | Short Ratio | 42.37 | Inst. Own | 15.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.67 | 200-d Avg | 3.71 | 1yr Est | 11.00 |
| Income Statement | |||
| Operating Expenses | 4.08M | ||
| Research and Development Expense | 2.23M | ||
| Selling, General and Administrative Expense | 1.85M | ||
| Operating Income | -4.08M | ||
| Interest Expense | 1.99M | ||
| Net Income | -5.05M | ||
| Net Income Common Stock | -5.07M | ||
| Net Income Common Stock (USD) | -5.07M | ||
| Consolidated Income | -5.05M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -3.06M | ||
| Earning Before Interest & Taxes (USD) | -3.06M | ||
| Preferred Dividends Income Statement Impact | 21.00K | ||
| Weighted Average Shares | 65.78M | ||
| Weighted Average Shares Diluted | 65.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.11M | ||
| Cash and Equivalents (USD) | 14.11M | ||
| Current Assets | 15.69M | ||
| Total Assets | 15.76M | ||
| Total Debt | 135.71M | ||
| Current Liabilities | 7.31M | ||
| Debt Non-Current | 135.71M | ||
| Total Liabilities | 146.00M | ||
| Accumulated Retained Earnings (Deficit) | -437.61M | ||
| Shareholders Equity | -131.96M | ||
| Shareholders Equity (USD) | -131.96M | ||
| Assets Non-Current | 68.00K | ||
| Total Debt (USD) | 135.71M | ||
| Liabilities Non-Current | 138.69M | ||
| Trade and Non-Trade Payables | 3.12M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.00K | ||
| Net Cash Flow from Financing | 257.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.61M | ||
| Issuance (Purchase) of Equity Shares | 257.00K | ||
| Net Cash Flow from Operations | -3.87M | ||
| Share Based Compensation | 686.00K | ||